Samjin Pharmaceutical Co., Ltd.
Records under this name other than the patents Samjin Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Samjin Pharmaceutical Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,301,291 | Novel Imidazole Derivative Having JNK Inhibitory Activity and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,420,963 | Novel Revamipide Prodrugs, Preparation Method and Use Thereof Formerly held Lapsed on the fee record Ended Aug 23, 2026 · High confidence | Lapsed on the fee record | Ended Aug 23, 2026 | High confidence |
| US 10,918,725 | Ophthalmic composition comprising rebamipide and method for preparing the same Lapsed on the fee record Ended Feb 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 16, 2025 | From the USPTO record |
| US 6,683,184 | Piperazine derivatives and process for the preparation thereof Term ended Term ended Mar 3, 2020 · From the USPTO record | Term ended | Term ended Mar 3, 2020 | From the USPTO record |
| US 6,274,732 | Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrim idinedione Term ended Term ended Dec 28, 2019 · From the USPTO record | Term ended | Term ended Dec 28, 2019 | From the USPTO record |
| US 6,028,195 | Piperazine derivatives and process for the preparation thereof Term ended Term ended Feb 27, 2018 · From the USPTO record | Term ended | Term ended Feb 27, 2018 | From the USPTO record |
| US 6,987,114 | Antiviral pyrimidinedione derivatives and process for the preparation thereof Lapsed on the fee record Ended Jan 17, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jan 17, 2018 | From the USPTO record |
| US 6,620,936 | 9-aminoacridine derivatives and process for the preparation thereof Lapsed on the fee record Ended Sep 16, 2011 · From the USPTO record | Lapsed on the fee record | Ended Sep 16, 2011 | From the USPTO record |
| US 7,230,105 | 9-aminoacridine derivatives and process for the preparation thereof Lapsed on the fee record Ended Jun 12, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2011 | From the USPTO record |
| US 6,136,815 | Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof Lapsed on the fee record Ended Oct 24, 2008 · From the USPTO record | Lapsed on the fee record | Ended Oct 24, 2008 | From the USPTO record |